Potent and Selective Biaryl Amide Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)-Reference-Cited by-同舟云学术

Potent and Selective Biaryl Amide Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)

Published:2022-12-13 Issue:1 Volume:14 Page:116-122
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Sokolsky Alexander¹^ORCID,Vechorkin Oleg¹,Hummel Joshua R.¹,Styduhar Evan D.¹,Wang Anlai¹,Nguyen Minh H.¹^ORCID,Ye Hai Fen¹,Liu Kai¹^ORCID,Zhang Ke¹,Pan Jun¹,Ye Qinda¹,Atasoylu Onur¹,Behshad Elham¹,He Xin¹,Conlen Patricia¹,Stump Kristine¹,Ye Min¹,Diamond Sharon¹,Covington Maryanne¹,Yeleswaram Swamy¹,Yao Wenqing¹

Affiliation:

1. Incyte Research Institute, 1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.2c00241

Reference23 articles.

1. Cancer immunotherapy using checkpoint blockade

2. Oncology Meets Immunology: The Cancer-Immunity Cycle

3. Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK/SAPK kinase cascade.

4. HPK1 as a novel target for cancer immunotherapy

5. HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of GNE-6893, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of HPK1;ACS Medicinal Chemistry Letters;2024-09-03

2. Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress;Expert Opinion on Therapeutic Targets;2024-04-02

3. Discovery of quinazoline HPK1 inhibitors with high cellular potency;Bioorganic & Medicinal Chemistry;2023-09